advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (14)
Showing records 1 to 14
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation26123 Treatment of glaucoma in patients with dry eye syndrome
Labbé A; Baudouin C
Journal Français d'Ophtalmologie 2010; 33: 285-290
25896 Incidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications
Fukuchi T; Wakai K; Suda K; Nakatsue T; Sawada H; Hara H; Ueda J; Tanaka T; Yamada A; Abe H
Clinical Ophthalmology 2010; 4: 203-209
25992 Cytometric assessment of cytostatic and cytotoxic effects of topical glaucoma medications on human epithelial corneal line cells
Pozarowska D; Pozarowski P; Darzynkiewicz Z
Cytometry Part B - Clinical Cytometry 2010; 78: 130-137
25888 Considerations in glaucoma therapy: Fixed combinations versus their component medications
Higginbotham EJ
Clinical Ophthalmology 2010; 4: 1-9
25717 The ocular surface in glaucoma
Baudouin C
Cornea 2009; 28: S14-S19
25674 Methazolamide calcium phosphate nanoparticles in an ocular delivery system
Chen R; Qian Y; Li R; Zhang Q; Liu D; Wang M; Xu Q
Yakugaku Zasshi 2010; 130: 419-424
25718 Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications
Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
Cornea 2010; 29: 618-621
26218 Time course of changes in ocular wavefront aberration after instillation of 0.5% timolol gel-forming solution
Hiraoka T; Daito M; Okamoto F; Kiuchi T; Hirohara Y; Mihashi T; Oshika T
British Journal of Ophthalmology 2010; 94: 433-439
25993 Evaluation of the biocompatibility of novel peptide hydrogel in rabbit eye
Liang L; Xu X-D; Chen C-S; Fang J-H; Jiang F-G; Zhang X-Z; Zhuo R-X
Journal of Biomedical Materials Research - Part B Applied Biomaterials 2010; 93: 324-332
26276 Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication
Uusitalo H; Chen E; Pfeiffer N; Brignole-Baudouin F; Kaarniranta K; Leino K; Puska P; Palmgren E; Hamacher T; Hofmann G
Acta Ophthalmologica 2010; 88: 329-336
25825 Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: Development, characterization, and evaluation
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
Journal of Drug Targeting 2010; 18: 292-302
26051 Molecularly imprinted therapeutic contact lenses
White CJ; Byrne ME
Expert Opinion on Drug Delivery 2010; 7: 765-780
25761 Preparation and evaluation of a contact lens vehicle for puerarin delivery
Xu J; Li X; Sun F
Journal of Biomaterials Science, Polymer Edition 2010; 21: 271-288
26064 Chitosan and its derivatives as intraocular penetration enhancers
Zambito Y; Di Colo G
Journal of Drug Delivery Science and Technology 2010; 20: 45-52
